Mean Reflected BSDE Driven by a Marked Point Process and Application in Insurance Risk Management
ESAIM: Control, Optimisation and Calculus of Variations · 2024 · 30 · 51
DOI: 10.1051/cocv/2024040 ↗Kurz gefasst
Fachartikel in der Zeitschrift ESAIM: Control, Optimisation and Calculus of Variations, online erschienen am 02.07.2024. Verfasst von Zihao Gu und 2 weiteren Autor:innen. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 35 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, Tian Yuan Mathematical Foundation.
Abstract (Originalsprache)
This paper aims to solve a super-hedging problem along with insurance re-payment under running risk management constraints. The initial endowment for the super-hedging problem is characterized by a class of mean reflected backward stochastic differential equation driven by a marked point process (MPP) and a Brownian motion. By Lipschitz assumptions on the generators and proper integrability on the terminal value, we give the well-posedness of this kind of BSDEs by combining a representation theorem with the fixed point argument.
Förderung
- National Natural Science Foundation of China
- Tian Yuan Mathematical Foundation
Zitieren
APA
Gu, Z., Lin, Y., & Xu, K. (2024). Mean Reflected BSDE Driven by a Marked Point Process and Application in Insurance Risk Management. ESAIM: Control, Optimisation and Calculus of Variations, 30, 51. https://doi.org/10.1051/cocv/2024040
Vancouver
Gu Z, Lin Y, Xu K. Mean Reflected BSDE Driven by a Marked Point Process and Application in Insurance Risk Management. ESAIM: Control, Optimisation and Calculus of Variations. 2024;30:51. doi:10.1051/cocv/2024040
BibTeX
@article{Gu2024,
author = {Gu, Zihao and Lin, Yiqing and Xu, Kun},
title = {Mean Reflected BSDE Driven by a Marked Point Process and Application in Insurance Risk Management},
journal = {ESAIM: Control, Optimisation and Calculus of Variations},
year = {2024},
volume = {30},
pages = {51},
doi = {10.1051/cocv/2024040}
}
EUVIMED